News / Press Releases
CIRS Introduces Improved Prostate Training Phantom
Addition of new, “realistic” features better simulate patient scanning
Oct 3, 2014 (Norfolk, Va.) CIRS recently introduced a new Prostate Training Phantom designed for use in both diagnostic and interventional procedures, which features partial bladder, digitally modeled prostate gland, seminal vesicles, urethra, and perineal membrane.
Proprietary CIRS materials, Zerdine® and Z-Skin™, are used to better emulate patient scanning with improved ultrasound contrast between the prostate and background tissue, and more accurately simulated rectal wall. The gel formulations provide CT, MR and elastography contrast for multi-modality imaging. The phantom accommodates end-fire and side-fire ultrasound transducers.
The phantom is available in two configurations: one with embedded lesions (Model 070L), and one without embedded lesions (Model 070S).
The Prostate Training Phantom joins the existing lineup of CIRS prostate phantoms (Model 053 series).
For more information about the CIRS Prostate Training Phantom, visit www.cirsinc.com.
CIRS, a Castleray company, is recognized worldwide for tissue simulation technology and is the leader in the manufacture of phantoms and simulators for quantitative densitometry, calibration, quality control and research in the field of medical imaging and radiotherapy. CIRS is headquartered in Norfolk, VA (USA) and distributes products worldwide.
Sales and Marketing Manager